Haemoglobinopathies congenital Terminated Phase 2 Trials for Tacrolimus (DB00864)

Also known as: Hemoglobinopathy / Haemoglobinopathies / Hemoglobinopathies / Haemoglobinopathy / Haemoglobinopathy NOS / Abnormal hemoglobin NOS

IndicationStatusPhase
DBCOND0026458 (Haemoglobinopathies congenital)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00034528Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or ThalassemiaTreatment